Skip to main content

Advertisement

Log in

SARS-CoV-2

Immune dysregulation in long COVID

  • News & Views
  • Published:

From Nature Immunology

View current issue Submit your manuscript

Profiling of plasma proteins in individuals with COVID-19 shows that complement activation and myeloid inflammation are major pathways in the pathogenesis of long COVID and identifies distinct profiles of immune dysregulation in individuals with long COVID, highlighting the heterogeneous and diverse nature of this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: Mechanisms that could underlie the different manifestations of long COVID.

References

  1. Menges, D. et al. PloS ONE 16, e0254523 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Davis, H. E., McCorkell, L., Vogel, J. M. & Topol, E. J. Nat. Rev. Microbiol. 21, 133–146 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Liew, F. Nat. Immunol. https://doi.org/10.1038/s41590-024-01778-0 (2024).

    Article  PubMed  Google Scholar 

  4. Cervia-Hasler, C. et al. Science 383, eadg7942 (2024).

    Article  CAS  PubMed  Google Scholar 

  5. Chen, T., Gai, W.-P. & Abbott, C. A. BioMed Res. Int. 2014, e209398 (2014).

    Google Scholar 

  6. Qi, S. Y., Riviere, P. J., Trojnar, J., Junien, J.-L. & Akinsanya, K. O. Biochem. J. 373, 179–189 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Cervia, C. et al. J. Allergy Clin. Immunol. 147, 545–557.e9 (2021).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank T. Hoch and A. Nicoletto for reading the manuscript. Funding was provided by Swiss National Science Foundation grants (4078P0-198431, 310030-200669 and 310030-212240 to O.B.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Onur Boyman.

Ethics declarations

Competing interests

O.B. is listed as an inventor on a patent application (PCT/EP2023/084859) on biomarkers in long COVID. L.C. has no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ceglarek, L., Boyman, O. Immune dysregulation in long COVID. Nat Immunol 25, 587–589 (2024). https://doi.org/10.1038/s41590-024-01795-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41590-024-01795-z

  • Springer Nature America, Inc.

Navigation